NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress
Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress
Read More
Tag: metabolic diseases
Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
Chronic liver disease and associated cirrhosis account for one million deaths every year
Read More
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
